


wishbone ( Date: 23-Aug-2010 22:54) Posted:
|
I was too slow to grab it at 0.480. Otherwise, at least have some kopi money.
I think tomorrow it will continue to rally.
Will put this counter in my radar screen.
Good Luck to those who vested.Cheong arh!!!!

now can still buy?

alexchia01 ( Date: 23-Aug-2010 14:15) Posted:
|
OMG! Another Final Dividend of $0.0135, XD on 22 Oct 2010.
Very Good!!!

If you are looking for mid term trading, TechOil&Gas is too high, so Innotek is a better choice. Although Innotek already in oversold position, but candlesticks still show bearishness. You may want to wait for a couple of days, make sure the price has stabilized before Buying.
If you are looking for long term investing, I think there is going to have a major market correction coming soon, maybe from Sep or Oct onward. You may want to wait for the correction to be over before Buying.
This is just my personal opinion, so don't blame me if I'm wrong.
Good luck.
tea444u ( Date: 23-Aug-2010 00:31) Posted:
|
Now is too late to Buy.
I'm already looking for the right time to take profit.
tea444u ( Date: 21-Aug-2010 23:50) Posted:
|
C & O PHARM TECH (HLDGS) LTD | DIVIDEND | 26 Aug 2010 | 30 Aug 2010 | 8 Sep 2010 | 2ND SP INTERIM SGD 0.028 |
C & O PHARM TECH (HLDGS) LTD | DIVIDEND | 8 Jul 2010 | 12 Jul 2010 | 30 Jul 2010 | SGD 0.005 |
C & O PHARM TECH (HLDGS) LTD | DIVIDEND | 8 Jul 2010 | 12 Jul 2010 | 30 Jul 2010 | SGD 0.035 |
verspact ( Date: 20-Aug-2010 14:36) Posted:
|
$0.012 anticipated by Philip Research.
If realized then whole year dividend is 0.08

alooloo ( Date: 22-Jul-2010 15:35) Posted:
|
well hope it able to maintain tt gain
Coming closer to Dividend
Might c further up in price
could it be the report that going to release on next Monday

Finally cheque came in, thks for the responses guys
Another announcement just made...

SINGAPORE – 3 August 2010 – Mainboard-listed C & O Pharmaceutical Technology (Holdings) Limited (“C&O” or “the Group”) today announced that the Group’s has secured a sales contract which brings a revenue of RMB32 million in three years with a third party for the exclusive distribution of C&O-developed Cidofovir Dihydrate. Cidofovir Dihydrate is an active pharmaceutical ingredient (API) for the production of Cidofovir, which is widely used in the United States. The distributor will be responsible to seek United States Food and Drug Administration (“U.S. FDA”) approval of C&O’s Cidofovir Dihydrate